Task: Answer the multiple-choice question.
Question: Which drug exhibits a 31.665% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) CN(C1CCCC1)C1CCN(C(=O)CNC(=O)/C=C/c2ccc(F)cc2)CC1
(b) COc1ccc(C(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1OC
(c) COc1ccc(-c2noc(CNC(=O)Nc3ccc(F)cc3)n2)cc1
(d) CC(=O)Nc1ccc(NS(=O)(=O)c2cn(C)c(=O)n(C)c2=O)cc1
(e) N#Cc1c(NCCO)ccc([N+](=O)[O-])c1NCCO
Answer: b. COc1ccc(C(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1OC
COc1ccc(C(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1OC
(3,4-dimethoxyphenyl)-spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,4'-piperidine]-1'-ylmethanone